AzTrials
AzTrials

HIV PreventionIFE4PrEPNCT05087927

Study for IFE4PrEP Intervention on PrEP Uptake by Southern African American Women

An observational study of HIV Prevention, run by University of North Carolina, Chapel Hill at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Purpose: This study is partnering with communities to identify the best ways to provide HIV prevention communication and services for women living in public housing who have been disproportionately affected by HIV but underserved by current HIV prevention programs. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
HIV Prevention
What is being tested?
Gain framing plus demographically targeted photos, Loss framing plus demographically targeted photos and Gain framing plus not demographically targeted photos
How many people
31 participants
Where
1 siteUnited States
Study dates
18 Apr 2023to 10 Mar 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The target population for this study is African American cisgender women at least 18 years old residing in DHA (Durham Housing Authority) community housing. The vast majority of DHA residents are African American, so the investigators anticipate recruiting participants who are majority African American without explicitly excluding prospective participants on the basis of race.

Who may be able to join

  • Women will be eligible to participate if they meet the following criteria:
  • 18 years of age or older
  • Identify as cisgender female (assigned female sex at birth and currently identify as female)
  • Currently reside in Durham Housing Authority (DHA) housing

Who cannot join

  • Women will not be eligible to participate if they meet the following criteria:
  • Younger than 18 years of age
  • Do not Identify as cisgender female (assigned female sex at birth and currently identify as female)
  • Do not currently reside in Durham Housing Authority (DHA) housing

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of North Carolina

    Chapel Hill, North Carolina, 27514

Other trials in United States

About this study

Official title: IGHID 12113 - Formative Study for I'm Fully Empowered4PrEP Intervention on HIV PrEP Uptake by Southern African American Women (IFE4PrEP Formative Study)

Purpose: This study is partnering with communities to identify the best ways to provide HIV prevention communication and services for women living in public housing who have been disproportionately affected by HIV but underserved by current HIV prevention programs. The investigators want to work with community members to develop and design the delivery of a program to promote awareness of and access to pre-exposure prophylaxis (PrEP) for HIV prevention among women living in public housing.

Participants: Up to 248 cisgender females who are 18 years of age or older and currently reside in Durham Housing Authority (DHA) housing will be enrolled in this study at UNC.

Procedures (methods): Data collection for this formative study will consist of 4 focus groups of up to 12 women in each focus group living in DHA as well as a survey of 200 women living in DHA.

Read the detailed description

Study Design

This observational formative study consists of cross-sectional data collection with women living in DHA (Durham Housing Authority) housing through surveys and focus group discussions. Both modes of data collection will service to collect descriptive information to refine the intervention. The survey will also include a randomized messaging experiment (see Data Collection Procedures description below).

Study Duration, Enrollment and Number of Subjects

This formative study will last up to one year (12 months). The investigators will enroll up to 248 participants (up to 200 survey participants and up to 48 focus group participants with some women participating in both) as recruitment allows and as necessitated by thematic saturation.

Study Population

The target population for this study is African American cisgender women at least 18 years old residing in DHA community housing. The vast majority of DHA residents are African American, so the investigators anticipate recruiting participants who are majority African American without explicitly excluding prospective participants on the basis of race. Women will be eligible to participate if they meet the following criteria:

  1. 18 years of age or older
  2. Identify as cisgender female (assigned female sex at birth and currently identify as female)
  3. Currently reside in Durham Housing Authority (DHA) housing

Data Collection Procedures

Survey

The self-administered electronic survey will assess the topics listed below and will include a randomized messaging experiment to assess the effect of exposure messaging about PrEP with variable framing on attitudes and perceived norms about PrEP. Participants will complete the survey as follows:

  • Women recruited through community network referral may complete the survey on their own device at the time of their choosing.
  • Women recruited through community/public events or FGDs will be provided the option to either: a) complete the self-administered electronic survey during the event on a study-owned device (if an in-person event). Limited literacy, vision-impaired, or any participant who desires assistance may request that a study staff member read the questions aloud to them for them to complete the survey, or request to complete the survey as an interviewer-administered survey in a private location; or b) complete the survey at a time of their choosing on their own device.

Survey topics will include:

  • Sociodemographic characteristics (age, race/ethnicity, DHA community of residence)
  • PrEP awareness \& knowledge
  • Attitudes toward PrEP
  • Randomized messaging experiment (see below)
  • Perceived PrEP norms
  • Perceived ability to access PrEP
  • Barriers and facilitators to using PrEP
  • Perceived HIV risk
  • HIV risk factors/behaviors
  • Likelihood to use PrEP/interest/willingness to use PrEP
  • Perceived stigmas

The survey will include an embedded randomized 2 x 2 between-subjects experiment (gain vs. loss framing by intrinsic vs. extrinsic motivation messaging) evaluating the effects of the alternative messaging approaches on intermediate endpoints in Table 3 of the protocol to identify the approaches most associated with positive PrEP attitudes and norms. The experiment will be embedded in a questionnaire administered before focus group sessions to 40 focus group participants and to 160 additional women in study communities (total of 200, 50 per community). During each of the 4 focus groups, the investigators also will explore women's reactions to alternative modes (e.g., flyers, posters, apps, social media) of PrEP messaging.

Hypotheses for each messaging attribute are as follows:

H1: Gain framing will be associated with more positive attitudes and more positive perceived norms about PrEP than loss framing.

  • Gain framing: PrEP puts me in control
  • Loss framing: Without PrEP, I'm less in control

H2: Demographic targeting will be associated with more positive attitudes and more positive perceived norms about PrEP than non-demographically targeted messaging.

  • Demographically targeted: [Image of African American woman]
  • Extrinsic framing: [Image of women of multiple races]

Focus Group Discussions (FGDs)

Focus Group participants will be given the option to participate in a focus group by Zoom or in person. Per North Carolina Executive Orders current at the time of data collection, the investigators anticipate that in-person FGDs will be conducted in a private indoor location with sufficient ventilation, 6-foot distancing between participants, and with face masks for both FGD facilitators and participants. Focus groups with limited participants showing up may be converted to individual in-depth interviews. With participant consent, FGDs will be audio-recorded for analysis. Zoom focus groups will be video/audio-recorded with the video deleted and the audio retained directly following the FGD. Focus groups will be led by trained study staff members who will facilitate a discussion on the topics below:

  • Current awareness \& knowledge of PrEP (including current sources of information about PrEP)
  • Attitudes toward PrEP (including any stigmas about PrEP, perceived risk)
  • Perceptions of and recommendations for messaging about PrEP use among cisgender women (open-ended then specific reactions)
  • Perceptions of and recommendations for messaging about PrEP mobile unit (open-ended then specific reactions)
  • Preferences for mobile PrEP unit delivery features (e.g., timing, location, appointment type, delivery of complementary services).
  • Best media/modes for providing messages about PrEP and the mobile unit to women in DHA.
  • Perceptions of peer networkers, best approach for contacting residents and providing information.
  • Barriers and facilitators to using PrEP
Conditions
HIV Prevention
Being tested
Gain framing plus demographically targeted photos, Loss framing plus demographically targeted photos, Gain framing plus not demographically targeted photos, Loss framing plus not demographically targeted photos
Keywords
HIV, pre-exposure prophylaxis, PrEP, Prevention, Women's Health, Health Messaging

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gain framing plus demographically targeted photosBehavioural

    Gain framing: Participant feels PrEP puts her in control

    Participants (majority of whom will be African American) will be shown an image of women of multiple races.

  • Loss framing plus demographically targeted photosBehavioural

    Loss framing: Without PrEP, participant feels less in control

    Participants (majority of whom will be African American) will be shown an image of women of multiple races.

  • Gain framing plus not demographically targeted photosBehavioural

    Gain framing: Participant feels PrEP puts her in control

    Participants (majority of whom will be African American) will be shown an image of an African American woman.

  • Loss framing plus not demographically targeted photosBehavioural

    Loss framing: Without PrEP, participant feels less in control

    Participants (majority of whom will be African American) will be shown an image of an African American woman.

Study groups in NCT05087927
Study groupRoleWhat they receive
Focus GroupThere will be 4 focus groups of up to 12 women in each focus group.
Receives: Behavioral: Gain framing plus demographically targeted photos; Behavioral: Loss framing plus demographically targeted photos; Behavioral: Gain framing plus not demographically targeted photos; Behavioral: Loss framing plus not demographically targeted photos
Survey GroupThere will be up to 200 women who complete the survey for this study.
Receives: Behavioral: Gain framing plus demographically targeted photos; Behavioral: Loss framing plus demographically targeted photos; Behavioral: Gain framing plus not demographically targeted photos; Behavioral: Loss framing plus not demographically targeted photos

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Modified Jaspal, Lopes, and Maatouk Attitudes toward PrEP Scale (APS)

    A subset of the Attitudes toward PrEP Scale (APS) will be used to assess the association between message exposure and attitudes toward pre-exposure prophylaxis (PrEP). This sub-set scale will include nine items rated on a 5-point Likert scale (responses ranging from 1=Strongly Disagree to 5=Strongly Agree). The nine items are a sub-set of the original APS scale and will include four items comprising sub-scale 2, three items comprising sub-scale 3, and two items from sub-scale 1. A mean score will be calculated for each complete sub-scale (2 and 3) ranging from 1-5. Each of the two items from sub-scale 1 will be scored individually, ranging from 1-5. Higher scores indicate more positive attitudes toward PrEP.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2021
  2. Study start18 Apr 2023
  3. Primary completion28 Nov 2023
  4. Study completion10 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05087927
Sponsor's protocol ID
21-1244
Acronym
IFE4PrEP
Status last verified
Sep 2024
First submitted
8 Oct 2021
Last updated
20 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of HIV Prevention, run by University of North Carolina, Chapel Hill at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Modified Jaspal, Lopes, and Maatouk Attitudes toward PrEP Scale (APS) (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Sep 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
IFE4PrEP Clinical Trial NCT05087927 | AzTrials